Bionomics to present BNC105 trial results of metastatic renal cancer at Asian ... - News-Medical.net PDF Print

News-Medical.net

Bionomics to present BNC105 trial results of metastatic renal cancer at Asian ...
News-Medical.net
Bionomics Limited (ASX: BNO, OTCQX: BNOEF) today announced that it will present a poster with new data on the DisrupTOR-1 trial of BNC105 in patients with metastatic renal cancer at the 7th Asian Oncology Summit being held from April 10-12, 2015 in ...
BNC105 Biomarker Data to Be Presented at Asian Oncology Conference SYS-CON Media (press release)

all 5 news articles »

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.